Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/69885
Campo DC Valoridioma
dc.contributor.authorGherardini, Jenniferen_US
dc.contributor.authorWegner, Jeannineen_US
dc.contributor.authorChéret, Jérémyen_US
dc.contributor.authorGhatak, Sushmitaen_US
dc.contributor.authorLehmann, Janinen_US
dc.contributor.authorAlam, Majiden_US
dc.contributor.authorJimenez, Franciscoen_US
dc.contributor.authorFunk, Wolfgangen_US
dc.contributor.authorBöhm, Markusen_US
dc.contributor.authorBotchkareva, Natalia V.en_US
dc.contributor.authorWard, Chrisen_US
dc.contributor.authorPaus, Ralfen_US
dc.contributor.authorBertolini, Martaen_US
dc.date.accessioned2020-02-05T12:51:00Z-
dc.date.accessioned2020-07-01T11:35:10Z-
dc.date.available2020-02-05T12:51:00Z-
dc.date.available2020-07-01T11:35:10Z-
dc.date.issued2019en_US
dc.identifier.issn0142-5463en_US
dc.identifier.otherScopus-
dc.identifier.urihttp://hdl.handle.net/10553/69885-
dc.description.abstractOBJECTIVES: Although the effect of ultraviolet radiation (UVR) on human skin has been extensively studied, very little is known on how UVR impacts on hair follicle (HF) homeostasis. Here, we investigated how solar spectrum UVR that hits the human skin surface impacts on HF biology, and whether any detrimental effects can be mitigated by a widely used cosmetic and nutraceutical ingredient, caffeine. METHODS: Human scalp skin with terminal HFs was irradiated transepidermally ex vivo using either 10 J/cm2 UVA (340-440 nm) + 20 mJ/cm2 UVB (290-320 nm) (low dose) or 50 J/cm2 UVA + 50 mJ/cm2 UVB (high dose) and organ-cultured under serum-free conditions for 1 or 3 days. 0.1% caffeine (5.15 mmol/L) was topically applied for 3 days prior to UV exposure with 40 J/cm2 UVA + 40 mJ/cm2 UVB and for 3 days after UVR. The effects on various toxicity and vitality read-out parameters were measured in defined skin and HF compartments. RESULTS: Consistent with previous results, transepidermal UVR exerted skin cytotoxicity and epidermal damage. Treatment with high and/or low UVA+UVB doses also induced oxidative DNA damage and cytotoxicity in human HFs. In addition, it decreased proliferation and promoted apoptosis of HF outer root sheath (ORS) and hair matrix (HM) keratinocytes, stimulated catagen development, differentially regulated the expression of HF growth factors, and induced perifollicular mast cell degranulation. UVR-mediated HF damage was more severe after irradiation with high UVR dose and reached also proximal HF compartments. The topical application of 0.1% caffeine did not induce skin or HF cytotoxicity and stimulated the expression of IGF-1 in the proximal HF ORS. However, it promoted keratinocyte apoptosis in selected HF compartments. Moreover, caffeine provided protection towards UVR-mediated HF cytotoxicity and dystrophy, keratinocyte apoptosis, and tendential up-regulation of the catagen-promoting growth factor. CONCLUSION: Our study highlights the clinical relevance of our scalp UV irradiation ex vivo assay and provides the first evidence that transepidermal UV radiation negatively affects important human HF functions. This suggests that it is a sensible prophylactic strategy to integrate agents such as caffeine that can act as HF photoprotectants into sun-protective cosmeceutical and nutraceutical formulations.en_US
dc.languageengen_US
dc.relation.ispartofInternational Journal of Cosmetic Scienceen_US
dc.sourceInternational journal of cosmetic science [ISSN 0142-5463], v. 41 (2), p. 164-182en_US
dc.subject320106 Dermatologíaen_US
dc.subject.otherCaffeineen_US
dc.subject.otherDelivery/Vectorization/Penetrationen_US
dc.subject.otherEx Vivo Modelen_US
dc.subject.otherHair Growthen_US
dc.subject.otherHair Treatmenten_US
dc.subject.otherUv Radiationen_US
dc.titleTransepidermal UV radiation of scalp skin ex vivo induces hair follicle damage that is alleviated by the topical treatment with caffeineen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1111/ics.12521en_US
dc.identifier.scopus85064967823-
dc.identifier.isi000465044300007-
dc.contributor.authorscopusid56157163700-
dc.contributor.authorscopusid57208510855-
dc.contributor.authorscopusid55053340100-
dc.contributor.authorscopusid57208510388-
dc.contributor.authorscopusid55872792000-
dc.contributor.authorscopusid57192083049-
dc.contributor.authorscopusid56526289400-
dc.contributor.authorscopusid22734045600-
dc.contributor.authorscopusid57201831190-
dc.contributor.authorscopusid6601993540-
dc.contributor.authorscopusid35082847000-
dc.contributor.authorscopusid34572423200-
dc.contributor.authorscopusid55053974600-
dc.description.lastpage182en_US
dc.identifier.issue2-
dc.description.firstpage164en_US
dc.relation.volume41en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid2168404-
dc.contributor.daisngid5869892-
dc.contributor.daisngid750407-
dc.contributor.daisngid5143335-
dc.contributor.daisngid1533401-
dc.contributor.daisngid6907032-
dc.contributor.daisngid864612-
dc.contributor.daisngid492149-
dc.contributor.daisngid62435-
dc.contributor.daisngid308940-
dc.contributor.daisngid30533401-
dc.contributor.daisngid1965-
dc.contributor.daisngid503554-
dc.description.numberofpages18en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Gherardini, J-
dc.contributor.wosstandardWOS:Wegner, J-
dc.contributor.wosstandardWOS:Cheret, J-
dc.contributor.wosstandardWOS:Ghatak, S-
dc.contributor.wosstandardWOS:Lehmann, J-
dc.contributor.wosstandardWOS:Alam, M-
dc.contributor.wosstandardWOS:Jimenez, F-
dc.contributor.wosstandardWOS:Funk, W-
dc.contributor.wosstandardWOS:Bohm, M-
dc.contributor.wosstandardWOS:Botchkareva, NV-
dc.contributor.wosstandardWOS:Ward, C-
dc.contributor.wosstandardWOS:Paus, R-
dc.contributor.wosstandardWOS:Bertolini, M-
dc.date.coverdateAbril 2019en_US
dc.identifier.ulpgces
dc.description.sjr0,494
dc.description.jcr1,673
dc.description.sjrqQ2
dc.description.jcrqQ3
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Patología y Tecnología médica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameJimenez Acosta,Francisco-
Colección:Artículos
Artículos
Vista resumida

Citas SCOPUSTM   

35
actualizado el 21-jul-2024

Citas de WEB OF SCIENCETM
Citations

35
actualizado el 21-jul-2024

Visitas

45
actualizado el 19-ago-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.